REYNARD MADRIAGA: Open Payments
NPI 1124582218 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 6 payments from 4 companies in 2025. Trend: 2023 $292 · 2024 $340 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $140 |
| SANOFI-AVENTIS U.S. LLC | 2 | $125 |
| Astellas Pharma US Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: TZIELD, Ozempic, Veozah, MOUNJARO.
Industry payments across NV — which companies pay providers there.
